SHILPA MEDICARE LIMITED 100PCT E.O.

Company Introduction:

Shilpa Medicare Limited is a prominent Indian pharmaceutical company established in 1987. The company is primarily engaged in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage formulations. Shilpa Medicare is particularly recognized for its strong presence and expertise in the oncology segment, producing a wide array of anti-cancer drugs. Beyond oncology, they also focus on various other therapeutic areas and are committed to innovation, quality, and compliance. The company operates multiple state-of-the-art manufacturing facilities that adhere to stringent international regulatory standards, including approvals from agencies like the US FDA and European GMP.

Business Type:

Manufacturer (Factory)

Shilpa Medicare Limited primarily manufactures and sells the following products:

Active Pharmaceutical Ingredients (APIs)

Oncology APIs: A wide range of active pharmaceutical ingredients used in cancer treatment, including but not limited to Capecitabine, Imatinib, Erlotinib, Gefitinib, Sunitinib, Pemetrexed, Lenalidomide, Bortezomib, and many others.

Non-Oncology APIs: Various active ingredients for non-cancer related therapeutic areas.

Finished Dosage Formulations (FDFs)

Oral Solid Dosages: Tablets and capsules, including specialized oncology formulations.

Parenteral Preparations: Injectables, including lyophilized (freeze-dried) products and liquid injectables, particularly for oncology.

Topical Formulations: Creams, ointments, and gels.

Ophthalmic Products: Eye drops and other ocular preparations.

Biologics and Biosimilars

Development and manufacturing of biological products, including biosimilars, often focused on oncology.

Contract Development and Manufacturing Services (CDMO)

Providing services for the development and manufacturing of both drug substances (APIs) and drug products (formulations) for other pharmaceutical companies. This includes process development, analytical development, and commercial manufacturing.